利润表
EDITAS MEDICINE, INC.
EDIT
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
40.52 | 32.31 | 78.12 | 19.71 | 25.54 | 90.73 | 20.53 | 31.94 | - | - |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - |
|
毛利润
|
40.52 | 32.31 | 78.12 | 19.71 | 25.54 | 90.73 | 20.53 | 31.94 | - | - |
|
营业费用
|
200.53 | 283.47 | 247.30 | 245.66 | 218.69 | 225.57 | 161.45 | 145.66 | 133.66 | 103.24 |
|
研发费用
|
89.95 | 199.25 | 177.65 | 174.96 | 142.51 | 158.00 | 96.90 | 90.65 | 83.16 | 56.98 |
|
销售、一般及行政费用
|
49.90 | 71.99 | 69.65 | 70.70 | 76.18 | 67.58 | 64.56 | 55.01 | 50.50 | 46.26 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-160.01 | -251.15 | -169.18 | -225.95 | -193.15 | -134.84 | -140.92 | -113.73 | -133.66 | -103.24 |
|
营业外收入
|
-0.05 | 14.06 | 15.96 | 5.52 | 0.64 | 18.86 | 7.18 | 3.77 | -0.39 | 0.01 |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - |
|
利息支出
|
6.17 | 2.13 | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
-2.19 | 0.00 | -1.60 | 1.29 | -1.70 | 16.26 | -0.14 | 0.33 | 0.59 | -0.06 |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - |
|
净利润
|
-160.06 | -237.09 | -153.22 | -220.43 | -192.50 | -115.98 | -133.75 | -109.95 | -120.32 | -97.18 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-160.01 | -251.15 | -169.18 | -225.95 | -193.15 | -134.84 | -140.92 | -113.73 | -133.66 | -103.24 |
|
基本每股收益
|
-1.80 | -2.88 | -2.02 | -3.21 | -2.85 | - | - | - | - | - |
|
稀释每股收益
|
-1.80 | -2.88 | -2.02 | -3.21 | -2.83 | - | - | - | - | - |
|
加权平均股数
|
88.75 | 82.34 | 75.97 | 68.66 | 67.62 | - | - | - | - | - |
|
稀释加权平均股数
|
88.75 | 82.34 | 75.97 | 68.66 | 67.62 | - | - | - | - | - |
|
综合收益
|
-160.33 | -237.02 | -149.42 | -223.54 | -192.95 | -116.13 | -133.61 | -109.91 | -120.40 | - |